The oncogenic microRNA hsa-miR-155-5p targets the transcription factor ELK3 and links it to the hypoxia response

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Robertson, E Douglas ^a,b,c,d   Wasylyk, Christine ^a,b,c,d   Ye, Tao ^a,b,c,d   Jung, Alain C ^d   Wasylyk, Bohdan ^a,b,c,d  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b CNRS   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HSA MICRORNA 155 5P; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MICRORNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 3; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; CHROMATIN; ELK3 PROTEIN, HUMAN; MIRN155 MICRORNA, HUMAN; ONCOPROTEIN; PROTEIN BINDING;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOINFORMATICS; CELL HYPOXIA; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE LOCATION; GENE TARGETING; GENETIC CONSERVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MIR155HG GENE; MOLECULAR DYNAMICS; MOUSE; NEGATIVE FEEDBACK; NEOPLASM; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RNA SEQUENCE; TRANSCRIPTION INITIATION SITE; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND HEALING; ANIMAL; ANOXIA; CELL LINE; CHEMISTRY; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; NUCLEOTIDE SEQUENCE; POSITION WEIGHT MATRIX; RNA INTERFERENCE;

3' UNTRANSLATED REGIONS; ANIMALS; ANOXIA; BASE SEQUENCE; BINDING SITES; CELL LINE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICE; MICRORNAS; POSITION-SPECIFIC SCORING MATRICES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84912050135     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113050     Document Type: Article

References (47)

1. Goda N, Kanai M (2012) Hypoxia-inducible factors and their roles in energy metabolism. International Journal of Hematology 95: 457-463.
2. Bertout JA, Patel SA, Simon MC (2008) The impact of O2 availability on human cancer. Nature Reviews Cancer 8: 967-975.
3. Mucaj V, Shay JES, Simon MC (2012) Effects of hypoxia and HIFs on cancer metabolism. International Journal of Hematology 95: 464-470.
4. Ke Q, Costa M (2006) Hypoxia-inducible factor-1 (HIF-1). Molecular Pharmacology 70: 1469-1480.
5. Gross C, Buchwalter G, Dubois-Pot H, Cler E, Zheng H, et al. (2007) The ternary complex factor net is downregulated by hypoxia and regulates hypoxiaresponsive genes. Molecular and Cellular Biology 27: 4133-4141.
6. Gross C, Dubois-Pot H, Wasylyk B (2008) The ternary complex factor Net/Elk- 3 participates in the transcriptional response to hypoxia and regulates HIF-1α 6. Oncogene 27: 1333-1341.
7. Buchwalter G, Gross C, Wasylyk B (2004) Ets ternary complex transcription factors. Gene 324: 1-14.
8. Giovane A, Pintzas A, Maira SM, Sobieszczuk P, Wasylyk B (1994) Net, a new ets transcription factor that is activated by Ras. Genes and Development 8: 1502-1513.
9. Buchwalter G, Gross C, Wasylyk B (2005) The ternary complex factor net regulates cell migration through inhibition of PAI-1 expression. Molecular and Cellular Biology 25: 10853-10862.
10. Zheng H, Wasylyk C, Ayadi A, Abecassis J, Schalken JA, et al. (2003) The transcription factor Net regulates the angiogenic switch. Genes and Development 17: 2283-2297.
11. Ayadi A, Zheng H, Sobieszczuk P, Buchwalter G, Moerman P, et al. (2001) Nettargeted mutant mice develop a vascular phenotype and up-regulate egr-1. EMBO Journal 20: 5139-5152.
12. Criqui-Filipe P, Ducret C, Maira SM, Wasylyk B (1999) Net, a negative Rasswitchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. EMBO Journal 18: 3392-3403.
13. Maira SM, Wurtz JM, Wasylyk B (1996) Net (ERP/SAP2), one of the Rasinducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop- helix motif. EMBO Journal 15: 5849-5865.
14. Serchov T, Dubois-Pot-Schneider H, Charlot C, Rosl F, et al. (2010) Involvement of net and Hif1 a in distinct yet intricately linked hypoxia-induced signaling pathways. Journal of Biological Chemistry 285: 21223-21232.
15. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, et al. (2007) A microRNA signature of hypoxia. Molecular and Cellular Biology 27: 1859-1867.
16. Shen G, Li X, Jia YF, Piazza GA, Xi Y (2013) Hypoxia-regulated microRNAs in human cancer. Acta Pharmacologica Sinica 34: 336-341.
17. Liao WL, Lin SC, Sunny Sun H, Tsai SJ (2014) Hypoxia-induced tumor malignancy and drug resistance: Role of microRNAs. Biomarkers and Genomic Medicine.
18. Peng H, Hamanaka RB, Katsnelson J, Hao LL, Yang W, et al. (2012) MicroRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism. FASEB Journal 26: 3140-3147.
19. Kong W, He L, Richards EJ, Challa S, Xu CX, et al. (2014) Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene 33: 679-689.
20. Bruning U, Cerone L, Neufeld Z, Fitzpatrick SF, Cheong A, et al. (2011) MicroRNA-155 promotes resolution of hypoxia-inducible factor 1a activity during prolonged hypoxia. Molecular and Cellular Biology 31: 4087-4096.
21. Oda Y, Nakajima M, Mohri T, Takamiya M, Aoki Y, et al. (2012) Aryl hydrocarbon receptor nuclear translocator in human liver is regulated by miR-24. Toxicology and Applied Pharmacology 260: 222-231.
22. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, et al. (2009) Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation. Molecular Cell 35: 856-867.
23. Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, et al. (2009) An integrated approach for experimental target identification of hypoxia-induced miR-210. Journal of Biological Chemistry 284: 35134-35143.
24. Chan SY, Loscalzo J (2010) MicroRNA-210: A unique and pleiotropic hypoxamir. Cell Cycle 9: 1072-1083.
25. Li JH, Liu S, Zhou H, Qu LH, Yang JH (2014) StarBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Research 42: D92-D97.
26. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, et al. (2011) StarBase: A database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Research 39: D202-D209.
27. Williams RL, Courtneidge SA, Wagner EF (1988) Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell 52: 121-131.
28. van Beijnum JR, van der Linden E, Griffioen AW (2008) Angiogenic profiling and comparison of immortalized endothelial cells for functional genomics. Experimental Cell Research 314: 264-272.
29. Fontijn RD, Volger OL, Fledderus JO, Reijerkerk A, De Vries HE, et al. (2008) SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function. American Journal of Physiology - Heart and Circulatory Physiology 294: H891-H900.
30. Odrowaz Z, Sharrocks AD (2012) ELK1 uses different DNA binding modes to regulate functionally distinct classes of target genes. PLoS Genetics 8.
31. Göke J, Chan Y-S, Yan J, Vingron M, Ng H-H (2013) Genome-wide Kinase- Chromatin Interactions Reveal the Regulatory Network of ERK Signaling in Human Embryonic Stem Cells. Molecular Cell 50: 844-855.
32. O'Geen H, Lin YH, Xu X, Echipare L, Komashko VM, et al. (2010) Genomewide binding of the orphan nuclear receptor TR4 suggests its general role in fundamental biological processes. BMC Genomics 11.
33. Babar IA, Czochor J, Steinmetz A, Weidhaas JB, Glazer PM, et al. (2011) Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biology and Therapy 12: 908-914.
34. Jiang S, Zhang HW, Lu MH, He XH, Li Y, et al. (2010) MicroRNA-155 functions as an oncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Research 70: 3119-3127.
35. Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, et al. (2012) TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res 40: D222-229.
36. Tsuchiya S, Fujiwara T, Sato F, Shimada Y, Tanaka E, et al. (2011) MicroRNA- 210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem 286: 420-428.
37. Hammond SM (2005) Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett 579: 5822-5829.
38. Ferrajoli A, Shanafelt TD, Ivan C, Shimizu M, Rabe KG, et al. (2013) Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood 122: 1891-1899.
39. Esnault C, Stewart A, Gualdrini F, East P, Horswell S, et al. (2014) Rho-actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts. Genes Dev 28: 943-958.
40. Wozniak MA, Cheng CQ, Shen CJ, Gao L, Olarerin-George AO, et al. (2012) Adhesion regulates MAP kinase/ternary complex factor exchange to control a proliferative transcriptional switch. Current Biology 22: 2017-2026.
41. Dai Y, Qiu Z, Diao Z, Shen L, Xue P, et al. (2012) MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/ SVneo cells via down-regulating cyclin D1. Placenta 33: 824-829.
42. Liu S, Yang Y, Wu J (2011) TNFa-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors. Biochemical and Biophysical Research Communications 414: 618-624.
43. Elton TS, Selemon H, Elton SM, Parinandi NL (2013) Regulation of the MIR155 host gene in physiological and pathological processes. Gene 532: 1-12.
44. Chen Z, Ma T, Huang C, Hu T, Li J (2014) The pivotal role of microRNA-155 in the control of cancer. J Cell Physiol 229: 545-550.
45. Higgs G, Slack F (2013) The multiple roles of microRNA-155 in oncogenesis. J Clin Bioinforma 3: 17.
46. Czyzyk-Krzeska MF, Zhang X (2014) MiR-155 at the heart of oncogenic pathways. Oncogene 33: 677-678.
47. Flynt AS, Lai EC (2008) Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genet 9: 831-842.